Response Genetics to secure $2 million in private placement
The company has entered into a purchase agreement with certain affiliated funds of Special Situations Funds to raise $2 million from the private placement of two million newly
Health innovation platform developer Aditxt and its fully owned subsidiary Ignite Proteomics have announced their plans for a business combination with a strategic partner that values the latter at an implied equity value of nearly $150m.
Initial findings from the ongoing open-label, multi-center study demonstrates that AT-101 can be administered safely with docetaxel and prednisone (D/P) in these patients. Investigators also observed clinical responses,
The Navistar RMT Thermocool catheter is used with Stereotaxis’s Niobe remote magnetic navigation system for mapping and radiofrequency ablation to treat irregular heartbeats, or cardiac arrhythmias. Stereotaxis expects